Journal
CURRENT MEDICINAL CHEMISTRY
Volume 21, Issue 34, Pages 3918-3935Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867321666140826115123
Keywords
A(2A)R antagonists; aqueous solubility; cancer immunotherapy; molecular modeling; parkinson's disease; PET imaging; X-ray crystallography
Ask authors/readers for more resources
The Adenosine A2A receptor is a member of the G-protein coupled receptor superfamily. It plays a key role in numerous physiological processes through the central nervous system and in peripheral tissues. Functional interactions between the A2A and dopamine D2 receptor has spurred interest in the use of antagonists as anti-Parkinson drugs. Additionally, oncology drugs are now being designed based on the potential for A2A antagonists to function as immunotherapeutics. From early studies based on classical xanthine type A2A antagonists through second generation agents, this mini review will cover aspects of the discovery, development, chemical synthesis and medicinal evaluation of this important class of drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available